Home > Publications database > A versatile silica nanoparticle platform for induction of T cell responses – applied for therapeutic vaccination against HPV16 E6/E7-positive tumors in MHC-humanized mice > print

001     304268
005     20250907022457.0
024 7 _ |a 10.1080/2162402X.2025.2548002
|2 doi
024 7 _ |a 2162-4011
|2 ISSN
024 7 _ |a 2162-402X
|2 ISSN
024 7 _ |a altmetric:180925961
|2 altmetric
037 _ _ |a DKFZ-2025-01809
082 _ _ |a 610
100 1 _ |a Kruse, Sebastian
|0 P:(DE-He78)2d912f097c2da0d6c989134e4e9aec18
|b 0
|e First author
|u dkfz
245 _ _ |a A versatile silica nanoparticle platform for induction of T cell responses – applied for therapeutic vaccination against HPV16 E6/E7-positive tumors in MHC-humanized mice
260 _ _ |a Abingdon
|c 2025
|b Taylor & Franics
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1756716693_32339
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:D410#LA:D410#
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Fricke, Lia T.
|0 0009-0002-9985-4227
|b 1
|e First author
700 1 _ |a Zottnick, Samantha
|0 P:(DE-He78)e03b110ee83e48c1f9c099c723c76e7e
|b 2
700 1 _ |a Schlosser, Ann-Katrin
|0 P:(DE-He78)ff47de23176dc3df5c2694e2679e4e3e
|b 3
|u dkfz
700 1 _ |a Grabowska, Agnieszka K.
|b 4
700 1 _ |a Feidt, Eva
|b 5
700 1 _ |a Uhl, Philipp
|0 0000-0002-8616-5599
|b 6
700 1 _ |a Junglas, Ellen
|b 7
700 1 _ |a Förster, Jonas
|0 P:(DE-He78)1dfe5fa05989d8b5eeb8bd098e2f1c1f
|b 8
|u dkfz
700 1 _ |a Blersch, Josephine
|0 0000-0003-0637-3273
|b 9
700 1 _ |a Denner, Philip
|0 0000-0002-4301-5013
|b 10
700 1 _ |a Günter, Manina
|0 P:(DE-He78)b676990c2f64e3295740d42e356fb053
|b 11
|u dkfz
700 1 _ |a Autenrieth, Stella
|0 P:(DE-He78)d3dbba28fe1239effd15962787cbc363
|b 12
|u dkfz
700 1 _ |a Fava, Eugenio
|0 0000-0002-3737-0334
|b 13
700 1 _ |a Mier, Walter
|b 14
700 1 _ |a Kübelbeck, Armin
|b 15
700 1 _ |a Riemer, Angelika
|0 P:(DE-He78)3743a1b712edca2ffa829b7096d7037e
|b 16
|e Last author
|u dkfz
773 _ _ |a 10.1080/2162402X.2025.2548002
|g Vol. 14, no. 1, p. 2548002
|0 PERI:(DE-600)2645309-5
|n 1
|p 2548002
|t OncoImmunology
|v 14
|y 2025
|x 2162-4011
909 C O |o oai:inrepo02.dkfz.de:304268
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)2d912f097c2da0d6c989134e4e9aec18
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 0009-0002-9985-4227
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)e03b110ee83e48c1f9c099c723c76e7e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)ff47de23176dc3df5c2694e2679e4e3e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)1dfe5fa05989d8b5eeb8bd098e2f1c1f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)b676990c2f64e3295740d42e356fb053
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)d3dbba28fe1239effd15962787cbc363
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)3743a1b712edca2ffa829b7096d7037e
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-10
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-10
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ONCOIMMUNOLOGY : 2022
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-08-08T20:23:20Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-08-08T20:23:20Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2024-08-08T20:23:20Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-10
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-10
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b ONCOIMMUNOLOGY : 2022
|d 2024-12-10
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-10
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-10
920 2 _ |0 I:(DE-He78)D410-20160331
|k D410
|l Immuntherapie und -prävention
|x 0
920 1 _ |0 I:(DE-He78)D410-20160331
|k D410
|l Immuntherapie und -prävention
|x 0
920 1 _ |0 I:(DE-He78)D431-20160331
|k D431
|l Dentritische Zellen bei Infektionen und Krebs
|x 1
920 0 _ |0 I:(DE-He78)D410-20160331
|k D410
|l Immuntherapie und -prävention
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D410-20160331
980 _ _ |a I:(DE-He78)D431-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21